Preoperative Cognitive Stratification of Older Elective Surgical Patients: A Cross-Sectional Study.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 27028776)

Published in Anesth Analg on July 01, 2016

Authors

Deborah J Culley1, Devon Flaherty, Srini Reddy, Margaret C Fahey, James Rudolph, Chuan Chin Huang, Xiaoxia Liu, Zhongcong Xie, Angela M Bader, Bradley T Hyman, Deborah Blacker, Gregory Crosby

Author Affiliations

1: From the *Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; †University of Cincinnati College of Medicine, Cincinnati, Ohio; ‡ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; §Department of Anesthesiology, Perioperative and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; ∥Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; ¶ Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School and Harvard School of Public Health, Boston, Massachusetts; and #Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.

Articles cited by this

Mild cognitive impairment. Lancet (2006) 10.21

Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med (2008) 5.34

Physical activity, including walking, and cognitive function in older women. JAMA (2004) 4.90

Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA (2012) 4.89

The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry (2000) 4.75

Cognitive trajectories after postoperative delirium. N Engl J Med (2012) 4.69

Clinical practice. Mild cognitive impairment. N Engl J Med (2011) 4.16

The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc (2003) 3.79

Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med (1995) 3.37

Slower walking speed forecasts increased postoperative morbidity and 1-year mortality across surgical specialties. Ann Surg (2013) 3.15

Dementia screening in primary care: is it time? JAMA (2007) 2.77

Association of incident dementia with hospitalizations. JAMA (2012) 2.74

Delirium accelerates cognitive decline in Alzheimer disease. Neurology (2009) 2.67

Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis. JAMA Intern Med (2015) 2.58

The efficacy of peri-operative interventions to decrease postoperative delirium in non-cardiac surgery: a systematic review and meta-analysis. Anaesthesia (2014) 2.10

Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg (2012) 1.94

Type and severity of cognitive decline in older adults after noncardiac surgery. Anesthesiology (2008) 1.90

Pre-existing cognitive impairment as a factor influencing outcome after cardiac surgery. Br J Anaesth (2001) 1.87

Delirium: an independent predictor of functional decline after cardiac surgery. J Am Geriatr Soc (2010) 1.82

Physician recognition of cognitive impairment: evaluating the need for improvement. J Am Geriatr Soc (2004) 1.82

Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement (2012) 1.77

Improving identification of cognitive impairment in primary care. Int J Geriatr Psychiatry (2006) 1.69

Major abdominal surgery in nursing home residents: a national study. Ann Surg (2011) 1.64

Review articles: postoperative delirium: acute change with long-term implications. Anesth Analg (2011) 1.60

Decline in cognitive and functional skills increases mortality risk in nondemented elderly. Neurology (2005) 1.56

Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc (2011) 1.50

Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol (2008) 1.41

Functional status after colon cancer surgery in elderly nursing home residents. J Am Geriatr Soc (2012) 1.39

Preexisting cognitive impairment in patients scheduled for elective coronary artery bypass graft surgery. Anesth Analg (2007) 1.30

Independent association between preoperative cognitive status and discharge location after cardiac surgery. Am J Crit Care (2011) 1.23

Implementing routine cognitive screening of older adults in primary care: process and impact on physician behavior. J Gen Intern Med (2007) 1.22

Improving dementia care: the role of screening and detection of cognitive impairment. Alzheimers Dement (2013) 1.19

Screening for cognitive impairment in an elderly veteran population: acceptability and results using different versions of the Mini-Cog. J Am Geriatr Soc (2011) 1.10

Who refuses the diagnostic assessment for dementia in primary care? Int J Geriatr Psychiatry (2006) 1.09

Preoperative assessment of the older patient: a narrative review. JAMA (2014) 1.09

Preoperative cognitive dysfunction is related to adverse postoperative outcomes in the elderly. J Am Coll Surg (2012) 1.06

Preventing delirium in older adults with recent hip fracture through multidisciplinary geriatric consultation. J Am Geriatr Soc (2012) 1.02

Executive function and depression as independent risk factors for postoperative delirium. Anesthesiology (2009) 1.02

Four sensitive screening tools to detect cognitive dysfunction in geriatric emergency department patients: brief Alzheimer's Screen, Short Blessed Test, Ottawa 3DY, and the caregiver-completed AD8. Acad Emerg Med (2011) 1.01

The accuracy of family physicians' dementia diagnoses at different stages of dementia: a systematic review. Int J Geriatr Psychiatry (2011) 0.98

Prospective cohort study of adverse events in older people admitted to the acute general hospital: risk factors and the impact of dementia. Int J Geriatr Psychiatry (2011) 0.98

Advancing age and 30-day adverse outcomes after nonemergent general surgeries. J Am Geriatr Soc (2013) 0.95

Preexisting cognitive impairment and mild cognitive impairment in subjects presenting for total hip joint replacement. Anesthesiology (2011) 0.93

Finding dementia in primary care: the results of a clinical demonstration project. J Am Geriatr Soc (2012) 0.91

Detecting cognitive impairment in individuals at risk for cardiovascular disease: the "Clock-in-the-Box" screening test. Int J Geriatr Psychiatry (2010) 0.90

Preoperative cognitive assessment of the elderly surgical patient: a call for action. Anesthesiology (2011) 0.89

Cognitive screening in community-dwelling elders: performance on the clock-in-the-box. Am J Med (2011) 0.85

Causes of hospital admission for people with dementia: a systematic review and meta-analysis. J Am Med Dir Assoc (2013) 0.84

Incidence of postoperative cognitive dysfunction after general or spinal anaesthesia for extracorporeal shock wave lithotripsy. Br J Anaesth (2014) 0.82

Sensitivity and specificity of the animal fluency test for predicting postoperative delirium. Can J Anaesth (2014) 0.77

Preoperative evaluation. Anesthesiology (1958) 0.76

Articles by these authors

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet (2007) 12.13

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation. Proc Natl Acad Sci U S A (2003) 8.92

Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature (2008) 6.89

Propagation of tau pathology in a model of early Alzheimer's disease. Neuron (2012) 6.23

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science (2007) 5.49

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex (2008) 5.36

Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol (2004) 4.89

Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci (2005) 4.71

Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet (2008) 4.66

The intensity and variation of surgical care at the end of life: a retrospective cohort study. Lancet (2011) 4.44

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol (2002) 4.42

Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A (2005) 4.34

Family-based association between Alzheimer's disease and variants in UBQLN1. N Engl J Med (2005) 4.34

Simulation-based trial of surgical-crisis checklists. N Engl J Med (2013) 4.14

Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci (2006) 4.14

Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A (2009) 3.86

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol (2007) 3.83

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77

Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75

Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science (2013) 3.59

MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage (2009) 3.57

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol (2002) 3.48

Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron (2008) 3.46

Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron (2013) 3.43

Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med (2011) 3.28

Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24

Caspase activation precedes and leads to tangles. Nature (2010) 3.24

Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci (2002) 3.20

Crisis checklists for the operating room: development and pilot testing. J Am Coll Surg (2011) 3.19

Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neuropathol Exp Neurol (2002) 3.12

Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol (2005) 3.10

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05

Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem (2003) 3.00

Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol (2006) 2.93

Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91

Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. Am J Geriatr Psychiatry (2004) 2.70

The memory effects of general anesthesia persist for weeks in young and aged rats. Anesth Analg (2003) 2.69

Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science (2009) 2.65

Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity. J Biol Chem (2004) 2.62

The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivo. Ann Neurol (2008) 2.54

Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. J Neurosci (2011) 2.53

Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron (2004) 2.53

Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol (2006) 2.47

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology (2013) 2.47

Psychiatric genetics: a survey of psychiatrists' knowledge, opinions, and practice patterns. J Clin Psychiatry (2005) 2.46

Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci (2010) 2.46

Long-term impairment of acquisition of a spatial memory task following isoflurane-nitrous oxide anesthesia in rats. Anesthesiology (2004) 2.45

Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. J Neurosci (2002) 2.44

gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science (2009) 2.43

The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci (2007) 2.42

Rats exposed to isoflurane in utero during early gestation are behaviorally abnormal as adults. Anesthesiology (2011) 2.41

Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One (2008) 2.35

Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology. Brain (2010) 2.33

The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology (2006) 2.26

Delirium is a serious and under-recognized problem: why assessment of mental status should be the sixth vital sign. J Am Med Dir Assoc (2007) 2.23

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc Natl Acad Sci U S A (2003) 2.13

Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review. Alzheimer Dis Assoc Disord (2003) 2.12

Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12

Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy. Diabetes Res Clin Pract (2013) 2.12

Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08

The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J Biol Chem (2005) 2.08

Preoperative electrocardiograms: patient factors predictive of abnormalities. Anesthesiology (2009) 2.05

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels. Arch Neurol (2003) 2.05

The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology (2011) 2.01

Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques. J Neurosci (2004) 1.99

2-deoxy-D-glucose enhances anesthetic effects in mice. Anesth Analg (2015) 1.99

Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci (2009) 1.99

Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J Clin Invest (2005) 1.94

Selective anesthesia-induced neuroinflammation in developing mouse brain and cognitive impairment. Anesthesiology (2013) 1.93

Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Arch Neurol (2008) 1.92

Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nat Med (2004) 1.91

Protecting patients from an unsafe system: the etiology and recovery of intraoperative deviations in care. Ann Surg (2012) 1.91

Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J (2010) 1.90

General anesthesia--minding the mind during surgery. N Engl J Med (2011) 1.89

The effects of isoflurane and desflurane on cognitive function in humans. Anesth Analg (2011) 1.88

Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry (2007) 1.88

Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β. Brain (2012) 1.87

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement (2011) 1.87

The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem (2005) 1.85

Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J Cell Sci (2003) 1.85

Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme. J Neurosci (2006) 1.83

Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia. J Gerontol A Biol Sci Med Sci (2006) 1.83

Uniform polarity microtubule assemblies imaged in native brain tissue by second-harmonic generation microscopy. Proc Natl Acad Sci U S A (2003) 1.81

Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations. J Neurosci (2003) 1.81

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett (2002) 1.79

American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry (2007) 1.79

TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem (2002) 1.77